Accumold

It’s finally here, and the Accumold team has arrived in Boston for DeviceTalks Boston. The event goes from October 8th – 10th at the Westin Boston Waterfront and is a must-attend event for companies and engineers working on next-gen MedTech devices and medical innovations that will change our world.
Accumold will be providing real micro molded parts from past MedTech projects and industry successes for participants to interact with and Accumold’s VP of Marketing and Customer Strategy will be on hand to answer technical questions and overall process questions. Don’t worry, he’s already prepared to answer the most common question he gets “woa, can you really mold parts  that small with plastic?” (The answer is “yes!”)
Keynoting DeviceTalks this year will be Steve MacMillan, CEO of  Hologic. MacMillan has a long history in the MedTech space focusing on women’s health, creating new technology focusing on breast, skeletal, perinatal, gynecological and aesthetic health issues women face throughout their lives.
This year, DeviceTalks Boston will also feature three new tracks created by people familiar with the industry. The ECO-System track is tackling common struggles in the MedTech industry for Boston device manufacturers (and others), the TECH track is focusing on new devices and new technology, and the Investment track will be a resource for companies looking for capital and investors to grow their operations.
Other keynote speakers include Campbell Rogers, MD, VP and Chief Medical Officers for HeartFlow, Todd M. Pope President and CEO of TransEnterix, and Heidi Dohse, Sr. Program Manager of Healthcare at Google plus  many others.
What Is DeviceTalks?
For those unaware, DeviceTalks is a MedTech industry event for the MedTech community meant to create a community and event to foster a free exchange of ideas and insight for leading pioneers and engineers in the MedTech space. The event is hosted by MassDevice, an online journal of record for the medical device (MedTech) industry.
If you can’t make it to Boston, but still have questions on precision micro injection molding, or a new MedTech device,  please reach out. We love to answer questions.

ANKENY, Iowa – Baseball season is just days away, but the Accumold marketing team is ready for a medical and wearable technology triple play of its own in with three trade shows in Berlin, Boston and Stuttgart at Wearable  Europe 2018,  Medtec Europe 2018 in Messe Stuttgart, Germany from April 17-19 and  BIOMEDevice Boston on April 18-19.
“We’ll cover all the bases with three separate teams, but we’ll be at full strength when it comes to telling the Accumold story of our unique micro-molding capabilities, innovative engineering technology and exceptional customer care. It’s a winning pitch for companies in the wearable technology and med-tech sectors that want to reach that next level of innovation,” said Aaron Johnson, Vice President of Marketing and Customer Strategy.
Wearable Europe will focus on wearable technologies and applications and their progress toward commercialization. Its conference program will consist of more than 250 speakers, including 50 experts specifically covering wearable technology.
Medtec Europe is considered to be the continent’s preeminent medical technology gathering, showcasing key trends and insights across the entire supply chain of the medical technology industry. The annual event “brings together companies in the medical device supply chain to share ideas, meet partners, and discover, experience and source products and services from all stages of production in order to create the next generation of medical devices,” according to its organizers.
 

Accumold Sales and Communications Teams Heads To Boston
BIOMEDevice Boston brings together more than 450 leading suppliers with 4,500-plus medical technology engineers and executives to discuss the full spectrum of med-tech manufacturing.
 
“New England is a medical technology powerhouse that’s churning out some of the latest innovations in new materials, intelligent sensors, testing solutions, components and just about anything else in the sector,” Johnson said. “It’s always fascinating to see what’s going on at BIOMEDevice Boston because we typically see opportunities where Accumold can help take concepts off the drawing board and into the marketplace.”